Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

WASp signaling in T-cell lymphomas

$4.87M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization University of Illinois At Chicago
Country United States
Start Date Jul 15, 2024
End Date Jun 30, 2029
Duration 1,811 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10945084
Grant Description

ABSTRACT Title: WASp signaling in T-cell lymphomas Peripheral T-cell lymphomas (PTCL) are aggressive disorders, with less than 50% overall survival after 2-3-years of diagnosis. These dismal outcomes are in no small part secondary to the limited number of available biomarkers of disease progression and the limited knowledge of T-cell lymphoma biology. Emergent evidence

indicates that the actin cytoskeleton plays a pivotal role during T-cell lymphomas' development and growth; however, actin-related proteins' role as actionable targets in T-cell lymphomas still needs to be defined. Our preliminary findings demonstrate that the actin regulatory protein Wiskott-Aldrich syndrome protein (WASp) is

associated with decreased event-free survival and promotes T-cell lymphoma growth and survival. In this proposal, we will leverage a genetically engineered murine (GEM) model that develops spontaneous peripheral T-cell lymphomas (SNF5FL/CD4cre), and we will capitalize on an international consortium of more than 100 T-cell

lymphoma cases collected with accompanying annotated clinical outcomes, to test the role of WASp during the assembly of actin-dependent signaling complexes upstream of oncogenic transcriptional signaling, and define the role of the tumor microenvironment driving WASp-dependent oncogenic signaling.

All Grantees

University of Illinois At Chicago

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant